These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22918779)
1. Personalized image-based radiation dosimetry for routine clinical use in peptide receptor radionuclide therapy: pretherapy experience. Celler A; Grimes J; Shcherbinin S; Piwowarska-Bilska H; Birkenfeld B Recent Results Cancer Res; 2013; 194():497-517. PubMed ID: 22918779 [TBL] [Abstract][Full Text] [Related]
2. Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE. Ilan E; Sandström M; Wassberg C; Sundin A; Garske-Román U; Eriksson B; Granberg D; Lubberink M J Nucl Med; 2015 Feb; 56(2):177-82. PubMed ID: 25593115 [TBL] [Abstract][Full Text] [Related]
3. Update: the case for patient-specific dosimetry in radionuclide therapy. Stabin MG Cancer Biother Radiopharm; 2008 Jun; 23(3):273-84. PubMed ID: 18593360 [TBL] [Abstract][Full Text] [Related]
4. Dosimetry in Peptide radionuclide receptor therapy: a review. Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G J Nucl Med; 2006 Sep; 47(9):1467-75. PubMed ID: 16954555 [TBL] [Abstract][Full Text] [Related]
5. A radionuclide dosimetry toolkit based on material-specific Monte Carlo dose kernels. Loudos G; Tsougos I; Boukis S; Karakatsanis N; Georgoulias P; Theodorou K; Nikita K; Kappas C Nucl Med Commun; 2009 Jul; 30(7):504-12. PubMed ID: 19430322 [TBL] [Abstract][Full Text] [Related]
10. A literature review of electronic portal imaging for radiotherapy dosimetry. van Elmpt W; McDermott L; Nijsten S; Wendling M; Lambin P; Mijnheer B Radiother Oncol; 2008 Sep; 88(3):289-309. PubMed ID: 18706727 [TBL] [Abstract][Full Text] [Related]
11. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52. Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756 [TBL] [Abstract][Full Text] [Related]
12. Systemic and locoregional dosimetry in receptor radionuclide therapy with peptides. Cremonesi M; Ferrari M; Bodei L; Tosi G; Paganelli G Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):288-95. PubMed ID: 17043626 [TBL] [Abstract][Full Text] [Related]
13. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study. Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233 [TBL] [Abstract][Full Text] [Related]
19. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu. Konijnenberg MW; Bijster M; Krenning EP; De Jong M J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075 [TBL] [Abstract][Full Text] [Related]
20. Monte Carlo treatment planning for molecular targeted radiotherapy within the MINERVA system. Lehmann J; Hartmann Siantar C; Wessol DE; Wemple CA; Nigg D; Cogliati J; Daly T; Descalle MA; Flickinger T; Pletcher D; Denardo G Phys Med Biol; 2005 Mar; 50(5):947-58. PubMed ID: 15798267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]